May 24, 2018
The Faculty Council of the University of Miami Miller School of Medicine held its first-ever awards program during its final meeting of the academic year on May 22. The atmosphere was just right for something new, with faculty members chatting amiably beside a well-stocked supper buffet, and live jazz adding a musical dimension to the event.
Read more about the Faculty Council awards »
May 01, 2018
John W. Hinkle, M.D., a second-year resident at Bascom Palmer Eye Institute, won the Downtown Miami race in the recent Mercedes Benz Corporate Run 2018, a 5K course that he completed in 14:13. Hinkle won the same race in 2017, with a time of 15:46. Another Bascom Palmer resident, Nathan Scott, M.D., placed second, finishing the race in 15:06. He placed seventh in 2017, with a time of 17:21.
Read more about Dr. Hinkle's victory »
April 16, 2018
Five Bascom Palmer Eye Institute faculty members are among those honored as the Top 100 Most Influential People in the World of Ophthalmology. Eduardo C. Alfonso, M.D., Philip J. Rosenfeld, M.D., Ph.D., Harry W. Flynn, Jr., M.D., Richard K. Parrish, II, M.D., and Sonia H. Yoo, M.D., were named to The Ophthalmologist Power List 2018.
Read more about Bascom Palmer »
March 26, 2018
Creed Pettit, a 9-year-old legally blind boy from Mount Dora, Florida, on March 22 became the first patient to undergo a landmark gene therapy surgery at Bascom Palmer Eye Institute, part of UHealth — the University of Miami Health System and the Miller School of Medicine. Creed was diagnosed at about age 2 with Leber congenital amaurosis, a blinding genetic disease caused by an RPE65 genetic mutation.
Read more about gene therapy »
March 20, 2018
Prominent speakers from Sylvester Comprehensive Cancer Center and other departments and centers at the University of Miami Miller School of Medicine came together with invited experts from the National Institutes of Health and other leading national scientific organizations for an interactive two-day symposium on systems biology and data science preceded by a Data Science Hackathon.
Read more about the symposium »
March 03, 2018
Nationally renowned philanthropist Lois Pope remembers all too well the struggle her mother, Anastasia Berrodin, experienced as her vision slowly disappeared, the heart breaking results of an incurable eye disease known as macular degeneration. But Mrs. Pope says she also vividly remembers the care shown by the physicians and staff at Bascom Palmer Eye Institute, as they tried in vain to slow the spread of the disease.
Read more about Lois Pope's gift to Bascom Palmer »
March 02, 2018
Lois Pope, who is one of the nation’s leading philanthropists and whose mother went blind after suffering from macular degeneration, is donating $12 million to the Bascom Palmer Eye Institute at the University of Miami Miller School of Medicine to establish a home for collaborative, cutting-edge macular degeneration and retinal diseases research and to create a clinical research endowment.
March 02, 2018
Monday, March 12, begins UHealth’s observance of Patient Safety Awareness Week — an annual national campaign to increase awareness about patient safety among health care professionals and the public. This year’s theme is “Every Day is Patient Safety Day!” — an affirmation of our dedication to creating the safest possible environment for our patients and for each other.
Read more about the 2018 Patient Safety Awareness Week schedule »
January 24, 2018
Bascom Palmer Eye Institute of the University of Miami Miller School of Medicine is proud to announce that two members of the graduating class of the pioneering Master of Science in Vision Science and Ophthalmology (MVSIO) graduate degree program have matched for ophthalmology residency programs.
Read more about the first MVSIO graduates »
January 10, 2018
Researchers from Sylvester Comprehensive Cancer Center and Bascom Palmer Eye Institute at the University of Miami Miller School of Medicine have uncovered evidence that genomic aberrations in uveal melanoma that lead to metastasis may occur far earlier in tumor evolution than previously believed. The findings fundamentally change the thinking about how this eye cancer progresses.
Read more about the study findings »
January 03, 2018
Optical coherence tomography (OCT) has saved Medicare $9 billion by reducing the frequency of anti-vascular endothelial growth factor injections used to treat patients with wet age-related macular degeneration (AMD), according to Philip Rosenfeld, M.D., Ph.D., of Bascom Palmer Eye Institute. “OCT monitoring significantly reduces the need for costly injections for wet AMD,” Rosenfeld told a Congressional delegation.
Read more about Dr. Rosenfeld »